Windlas Biotech Limited
Windlas Biotech Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: WINDLAS and BSE: 543329 (ISIN INE0H5O01029).
It has a market capitalisation of ₹1,912 crore, a last close of ₹906.10 on 2026-10-19, a one-year return of -2.3%.
Valuation: a price-to-earnings ratio of 28.78x, a price-to-book ratio of 3.29x, a dividend yield of 0.7%.
Profitability: return on equity of 12.2%, return on capital employed of 16.7%, an operating margin of 11.6%.
Growth: sales growth of 20.8% a year over three years, net profit growth of 16.0% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.05x, promoter holding of 63.3%.
| Metric | Value |
|---|---|
| Market capitalisation | 1,912 |
| Last close | ₹906.10 |
| P/E (TTM) | 28.78x |
| P/B | 3.29x |
| Dividend yield | 0.7% |
| ROE (FY) | 12.2% |
| ROCE (FY) | 16.7% |
| Operating margin (TTM) | 11.6% |
| Sales growth, 3-year CAGR | 20.8% |
| Profit growth, 3-year CAGR | 16.0% |
| Debt / equity | 0.05x |
| Promoter holding | 63.3% |
| 1-year return | -2.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means